Literature DB >> 18461621

Oral mucosal reactivation rates of herpesviruses among HIV-1 seropositive persons.

Elizabeth Griffin1, Elizabeth Krantz, Stacy Selke, Meei-Li Huang, Anna Wald.   

Abstract

Herpes simplex virus, cytomegalovirus and Epstein-Barr virus infections are prevalent among HIV-1 infected persons. The relationships between salivary shedding of these herpesviruses have not been characterized. Salivary samples were collected on a median of 61 consecutive days from 41 HIV-1 seropositive persons and tested for HSV-1, HSV-2, CMV and EBV. HSV was detected on 5%, CMV on 19% and EBV on 71% of the days of sampling. HSV shedding was not related to CMV or EBV shedding rates. Persons with EBV shedding rates >40% had CMV DNA detected in their saliva significantly more often than those with EBV shedding rates <or=40% (P=0.008). The odds of detecting CMV were greater on days with HSV (OR 2.5, 95% CI 1.4, 4.4) or EBV (OR 3.8, 95% CI 1.9, 7.9) shedding. No significant associations between HSV shedding rates and CD4 count, plasma HIV-1 RNA or HAART were observed. Increasing plasma HIV-1 RNA was associated with greater frequency (P=0.01) and quantity (P<0.001) of EBV shedding. Among persons not receiving HAART, CD4 counts >200 cells/mm(3) were associated with lower frequency (P=0.02) and quantity (P=0.03) of CMV compared with CD4 counts <or=200 cells/mm(3). These data suggest that separate factors influence mucosal shedding of each of the three classes of herpesviruses but that virological interactions between the pathogens also exist.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18461621     DOI: 10.1002/jmv.21214

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Mechanisms of viral infections associated with HIV: workshop 2B.

Authors:  S M Tugizov; J Y Webster-Cyriaque; S Syrianen; A Chattopadyay; H Sroussi; L Zhang; A Kaushal
Journal:  Adv Dent Res       Date:  2011-04

2.  Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection.

Authors:  Christof Geldmacher; Richard A Koup
Journal:  Trends Immunol       Date:  2012-03-05       Impact factor: 16.687

3.  Valganciclovir for the Suppression of Epstein-Barr Virus Replication.

Authors:  Jessica E Yager; Amalia S Magaret; Steven R Kuntz; Stacy Selke; Meei-Li Huang; Lawrence Corey; Corey Casper; Anna Wald
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

4.  Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.

Authors:  Chunmei C Wang; Luis C Yepes; Robert J Danaher; Joseph R Berger; Yunanan Mootoor; Richard J Kryscio; Craig S Miller
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-02

Review 5.  Human cytomegalovirus tropism for mucosal myeloid dendritic cells.

Authors:  Laura Hertel
Journal:  Rev Med Virol       Date:  2014-06-02       Impact factor: 6.989

6.  Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV.

Authors:  Monique van Velzen; Werner J D Ouwendijk; Stacy Selke; Suzan D Pas; Freek B van Loenen; Albert D M E Osterhaus; Anna Wald; Georges M G M Verjans
Journal:  J Med Virol       Date:  2013-06-18       Impact factor: 2.327

7.  Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection.

Authors:  Christof Geldmacher; Njabulo Ngwenyama; Alexandra Schuetz; Constantinos Petrovas; Klaus Reither; Edwin J Heeregrave; Joseph P Casazza; David R Ambrozak; Mark Louder; William Ampofo; Georgios Pollakis; Brenna Hill; Erica Sanga; Elmar Saathoff; Leonard Maboko; Mario Roederer; William A Paxton; Michael Hoelscher; Richard A Koup
Journal:  J Exp Med       Date:  2010-11-29       Impact factor: 14.307

8.  HIV-1 replication activates CD4+ T cells with specificities for persistent herpes viruses.

Authors:  Anna Haas; Manuela Rehr; Frederik Graw; Peter Rusert; Walter Bossart; Herbert Kuster; Alexandra Trkola; Huldrych F Günthard; Annette Oxenius
Journal:  EMBO Mol Med       Date:  2010-06       Impact factor: 12.137

9.  Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques.

Authors:  Meropi Aravantinou; Olga Mizenina; Giulia Calenda; Jessica Kenney; Ines Frank; Jeffrey D Lifson; Moriah Szpara; Lichen Jing; David M Koelle; Natalia Teleshova; Brooke Grasperge; James Blanchard; Agegnehu Gettie; Elena Martinelli; Nina Derby
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

10.  HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread.

Authors:  Irna Sufiawati; Sharof M Tugizov
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.